Get Live Data

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Synairgen Share Price
  4. Synairgen Share Regulatory News
  5. Holding(s) in Company

Pin to quick picksSynairgen Regulatory News (SNG)

Synairgen Information
  • There is currently no data for SNG

Holding(s) in Company

21 Aug 2020 17:28

RNS Number : 8824W
Synairgen plc
21 August 2020
Ā 

Synairgen plc

("Synairgen" or the "Company")

Holding(s) in Company

Ā 

Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 21 August 2020 that Leonard Licht, a private investor, now holds 7,375,000 ordinary shares of 1 penceĀ each in the capital of the Company, representing 4.93% of the Company's issued share capital.

Enquiries:

Synairgen plc

+44 (0) 23 8051 2800

Richard Marsden (Chief Executive Officer)John Ward (Finance Director)

finnCap - nominated adviser and broker

+44 (0) 20 7220 0500

Geoff Nash, Kate Bannatyne, Charlie Beeson (Corporate Finance)Alice Lane, Manasa Patil (ECM)

Consilium Strategic Communications - financial media and investor relations adviser

+44 (0) 20 3709 5700

Mary-Jane Elliott, Sue Stuart, Olivia Manser

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Ā 
END
Ā 
Ā 
HOLFLFFRTRILFII
12345678910
Date   Source Headline
9th Apr 20257:00 amRNSCancellation - Synairgen plc
3rd Apr 20257:00 amRNSUpdate on trading post cancellation
28th Mar 20252:21 pmRNSResult of General Meeting
11th Mar 20257:00 amRNSProposed cancellation of trading on AIM
17th Jan 202512:55 pmRNSHolding(s) in Company
16th Jan 20253:42 pmRNSMartin Murphy appointed as Non-Executive Director
16th Jan 20253:42 pmRNSResult of General Meeting and Total Voting Rights
15th Jan 20255:37 pmRNS£18m raised to fund Phase 2 INVENT clinical trial
20th Dec 20247:00 amRNSProposed Fundraising
30th Oct 20246:09 pmRNSExercise of Share Options and Total Voting Rights
10th Oct 20245:05 pmRNSResults of AGM and Appointment of New Chairman
26th Sep 20247:00 amRNSInterim Results
18th Sep 20247:00 amRNSAppointment of New Chairman and Notice of AGM
5th Sep 20247:00 amRNSBoard Change
27th Jun 20247:00 amRNS2023 Full Year Results
15th Nov 20237:00 amRNSGrant of Options
11th Oct 20237:00 amRNSAppointment of New Chief Financial Officer
3rd Oct 20237:00 amRNSAppointment of Chief Medical Officer
21st Sep 20237:00 amRNSInterim Results
29th Jun 20236:02 pmRNSResult of AGM
29th Jun 202310:00 amRNSAnnual General Meeting Presentation
22nd Jun 20237:00 amRNSGrant of Options
23rd May 20237:00 amRNSPosting of Annual Report and Notice of AGM
27th Apr 20237:00 amRNS2022 Full Year Results
17th Apr 20237:00 amRNSNotice of Full Year results
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20234:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20234:35 pmRNSPrice Monitoring Extension
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Dec 202211:30 amRNSSPRINTER Trial Results Published
14th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSBoard Changes
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20224:40 pmRNSSecond Price Monitoring Extn
3rd Nov 20224:35 pmRNSPrice Monitoring Extension
20th Oct 20224:35 pmRNSPrice Monitoring Extension
6th Oct 20221:35 pmRNSHolding(s) in Company
4th Oct 20227:02 amRNSData from the US NIH-led ACTIV-2 Phase 2 trial
29th Sep 20227:01 amRNSBoard Changes
29th Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSSPRINTER Long COVID data presented at IDWeek
15th Sep 20227:00 amRNSNotice of Interim Results
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSPositive Findings from SG015 Tri-al Analysis
5th Sep 20227:00 amRNSCompany Announce Collaboration on UNIVERSAL Trial
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
TSTL
Tristel
LSE
0.00%
EIG
EI Group
LSE
0.00%
SNN
SNN.L
LSE
0.00%
PHNX
Phoenix Group Holdings
LSE
0.00%
HRI
Herald Investment Trust
LSE
0.00%
Trending
MPL
Mercantile Ports & Logistics
LSE
-9.68%
GEX
Georgina Energy
LSE
-0.88%
GST
GSTechnologies
LSE
5.88%
RRR
Red Rock Resources
LSE
0.00%
GGP
Greatland Resources
LSE
-1.08%